LoadingCABR
Melton Christopher reported Grant or award in Caring Brands, Inc.: 50000 units of Stock Option (Right to Buy) (derivative), dated 2026-09-28. The full Form 4 contains 1 transaction entry.
CABR
Alila Hector W reported Grant or award in Caring Brands, Inc.: 50000 units of Stock Option (Right to Buy) (derivative), dated 2026-09-28. The full Form 4 contains 1 transaction entry.
MNSO
Zhang Jingjing Eason reported Purchase in MINISO Group Holding Ltd: 150600 units of Ordinary Shares, dated 2026-09-29. The full Form 4 contains 1 transaction entry.
STGC
Strassman Hunter reported Grant or award in StartEngine Inc.: 6000000 units of Restricted Stock Unit (derivative), dated 2026-09-28. The full Form 4 contains 1 transaction entry.
MONIX
Meli Ali reported Purchase in Monachil Credit Income Fund: 8423.114 units of Class I Shares, dated 2026-09-25. The full Form 4 contains 2 transaction entries.
VRXA
Hosseinion Warren reported Purchase in Veraxa Biotech AG: 6024 units of Ordinary Shares, dated 2026-09-10. The full Form 4 contains 1 transaction entry.
CRAFX
Williams Paul Jay reported Purchase in Cascade Real Assets Fund: 22000 units of Class I Shares, dated 2026-09-25. The full Form 4 contains 2 transaction entries.
Simmons James H. III reported Grant or award in Apollo Asset Backed Credit Co LLC: 2016.503 units of E Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
Chrystal John C reported Grant or award in Apollo Asset Backed Credit Co LLC: 2016.503 units of E Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
Kasdin Robert A reported Grant or award in Apollo Asset Backed Credit Co LLC: 2016.503 units of E Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
Marano Thomas F. reported Grant or award in Apollo Asset Backed Credit Co LLC: 2016.503 units of E Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
ABEO
Vasanthavada Madhav reported Sale in ABEONA THERAPEUTICS INC.: 4902 units of Common Stock, dated 2026-09-29. The full Form 4 contains 1 transaction entry.
ABEO
O'Malley Brendan M. reported Sale in ABEONA THERAPEUTICS INC.: 6727 units of Common Stock, dated 2026-09-29. The full Form 4 contains 1 transaction entry.
ABEO
Vazzano Joseph Walter reported Sale in ABEONA THERAPEUTICS INC.: 9191 units of Common Stock, dated 2026-09-29. The full Form 4 contains 1 transaction entry.
ABEO
Seshadri Vishwas reported Sale in ABEONA THERAPEUTICS INC.: 19608 units of Common Stock, dated 2026-09-29. The full Form 4 contains 1 transaction entry.
ADRX
LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. reported Conversion in ADARx Pharmaceuticals, Inc.: 8908775 units of Common Stock, dated 2026-09-28. The full Form 4 contains 12 transaction entries.
SNEX
Smith Philip Andrew reported Exercise or conversion in StoneX Group Inc.: 56250 units of Common Stock, dated 2026-09-28. The full Form 4 contains 3 transaction entries.
ADRX
George Simeon reported Conversion in ADARx Pharmaceuticals, Inc.: 3334938 units of Common Stock, dated 2026-09-28. The full Form 4 contains 15 transaction entries.
ADRX
SR ONE CAPITAL MANAGEMENT, LLC reported Conversion in ADARx Pharmaceuticals, Inc.: 3334938 units of Common Stock, dated 2026-09-28. The full Form 4 contains 15 transaction entries.
PLAB
Park Han Kyung reported Sale in PHOTRONICS INC: 9500 units of COMMON STOCK, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
ATER
Lazar David E. reported Conversion in Aterian, Inc.: 1300530 units of Common Stock, dated 2026-09-24. The full Form 4 contains 4 transaction entries.
STEM
Carlson Michael James reported Exercise or conversion in STEM, INC.: 305 units of Common Stock, Par Value $0.0001 Per Share, dated 2026-09-26. The full Form 4 contains 3 transaction entries.
DFTX
Roberts Brandi reported Sale in Definium Therapeutics, Inc.: 3377 units of Common Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
ATER
NATAN DAVID reported 301,205 shares of Common Stock in Aterian, Inc. as grants or awards dated 2026-09-25. The Form 4 was disclosed on Sep 30, 2026. These were stock awards, not open-market purchases.
